PMID,Title,Journal,Year
40361517,Survival Benefits of GLP-1 Receptor Agonists in Patients with Neuroendocrine Neoplasms: A Large-Scale Propensity-Matched Cohort Study.,Cancers,2025
40163867,Rheumatology: What You May Have Missed in 2024.,Annals of internal medicine,2025
40094000,Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progression.,npj metabolic health and disease,2025
39777709,Prognostic impact of glucagon-like peptide-1 receptor (GLP1R) expression on cancer survival and its implications for GLP-1R agonist therapy: an integrative analysis across multiple tumor types.,GeroScience,2025
38796653,Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial.,Nature medicine,2024
38554713,Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis.,The lancet. Diabetes & endocrinology,2024
37599056,"Letter to Editor. Re ""de Leeuw SP, et al. Analysis of Serious Weight Gain in Patients Using Alectinib for ALK Positive Lung Cancer,"" Semaglutide a Potential Treatment for Serious Weight Gain From ALK Tyrosine Kinase Inhibitors?",Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,2023
